Table 2.

The comparison of MetS components at baseline and follow-up, by gender

MetS and its components	Men			Women			Total
	Baseline (2005-2016)	Follow-up (2015-2016)	P	Baseline (2005-2006)	Follow-up (2015-2016)	P	Baseline (2005-2006)	Follow-up (2015-2016)	P
FBG (mg/dL)	116.1±49.5	133.7±60.7	P<0.001	116.5±52.7	128.7±49.3	P<0.001	116.3±51	131.2±55.4	P<0.001
SBP (mmHg)	135.6±13.9	151.1±78.4	P<0.001	133.1±15.5	139.1±56	0.481	134.2±14.8	145.1±68.3	0.001
DBP (mmHg)	86.6±9	85.3±29.7	0.003	84.9±9.3	85.1±35.1	0.055	85.8±9.2	85.2±32.4	P<0.001
TG (mg/dL)	238.2±117.9	182.2±95.8	P<0.001	226.1±108.4	187.2±102.9	P<0.001	232.2±113.4	184.7±99.3	P<0.001
HDL-C (mg/dL)	47.8±13.3	37.7±6.9	P<0.001	52.8±13.5	43.1±7.9	P<0.001	50.2±13.6	40.3±7.9	P<0.001
WC (cm)	100.4±8.7	104.4±9.2	P<0.001	100.3±10.1	107.3±11.2	P<0.001	100.3±9.4	105.8±10.3	P<0.001

Data presented as mean±SD. Mean differences between components of MetS in Phase I and Phase II analyzed using paired t-test. FBG, fasting blood glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, blood pressure; TG, triglyceride; HDL-C, high-density lipoprotein-cholesterol; WC, waist circumference; MetS, metabolic syndrome